Nurullina G N, Pushkarev I N, Przhiyalkovskaya E G
The First Republican Clinical Hospital of Udmurt Republic.
Izhevsk State Medical Academy.
Probl Endokrinol (Mosk). 2024 Nov 4;70(5):14-22. doi: 10.14341/probl13423.
The aim of this review is to summarize the data available in the literature on the causes of headache in patients with acromegaly, as well as on the effect of various methods of acromegaly treatment on headache. Publications were searched in the PubMed database using the keywords «Headache in patients with acromegaly», «Headache in patients with pituitary adenomas», «Tension-type headache», «Migraine». Headache in patients with pituitary adenomas secreting somatotropic hormone (STH) is not uncommon: according to various authors, cephalgic syndrome occurs in 30-70% of patients with acromegaly and can worsen their quality of life, along with other factors, up to disability. By the nature of development, headache with acromegaly is classified into primary (migraine, tension headache, trigeminal autonomic cephalgia, for example, SUNCT syndrome and cluster headaches), and can also be caused by various causes directly related to the tumor. All this requires differential diagnosis. The factors causing headaches in somatotropinomas have not yet been well studied and require further research. These include the mass effect of the tumor, hormonal hypersecretion, pathology of the temporomandibular joint, sodium and fluid retention in the body, psychological factors, etc. The authors evaluated the effect on headache of various methods of acromegaly treatment: transnasal transsphenoidal adenomectomy, radiation therapy and drug therapy with somatostatin analogues, dopamine agonists and growth hormone receptor antagonist. However, even when normal levels of STH and insulin-like growth factor 1 (IGF-1) are reached, cephalgic syndrome may persist, therefore patients should be warned about this in advance and referred to a cephalgologist to select adequate headache therapy.
本综述的目的是总结文献中有关肢端肥大症患者头痛原因的数据,以及各种肢端肥大症治疗方法对头痛的影响。使用关键词“肢端肥大症患者的头痛”、“垂体腺瘤患者的头痛”、“紧张型头痛”、“偏头痛”在PubMed数据库中搜索相关出版物。分泌生长激素(STH)的垂体腺瘤患者出现头痛并不罕见:根据不同作者的研究,30%-70%的肢端肥大症患者会出现头痛综合征,这可能会与其他因素一起恶化他们的生活质量,甚至导致残疾。从发病性质来看,肢端肥大症引起的头痛可分为原发性(例如偏头痛、紧张性头痛、三叉自主神经性头痛,如SUNCT综合征和丛集性头痛),也可能由与肿瘤直接相关的各种原因引起。所有这些都需要进行鉴别诊断。生长激素瘤导致头痛的因素尚未得到充分研究,需要进一步研究。这些因素包括肿瘤的占位效应、激素分泌过多、颞下颌关节病变、体内钠和液体潴留、心理因素等。作者评估了各种肢端肥大症治疗方法对头痛的影响:经鼻蝶窦腺瘤切除术、放射治疗以及使用生长抑素类似物、多巴胺激动剂和生长激素受体拮抗剂的药物治疗。然而,即使生长激素和胰岛素样生长因子1(IGF-1)达到正常水平,头痛综合征仍可能持续存在,因此应提前告知患者这一情况,并将其转诊至头痛专家处,以选择合适的头痛治疗方法。
Probl Endokrinol (Mosk). 2024-11-4
Baillieres Clin Endocrinol Metab. 1995-4
Growth Horm IGF Res. 2003-8
Expert Rev Endocrinol Metab. 2019-3
Medicine (Baltimore). 2023-10-20
J Neurol. 2023-7
Dent Clin North Am. 2023-4
Endocr Relat Cancer. 2023-3-1
Nutr Metab Cardiovasc Dis. 2023-2
J Endocr Soc. 2022-7-26
J Neurol Surg B Skull Base. 2021-5-29